Nearly half of seniors quit GLP-1 weight-loss drugs within a year. Experts reveal why older Americans abandon medications ...
MedPage Today on MSN
GLP-1 Agents Showed Broader Risks, Rewards in 2025
Meanwhile, in attempts to address long-standing thyroid cancer concerns, a research team conducted a 350,000-person analysis ...
Hone Health reports that GLP-1 medications are increasingly prescribed for weight loss and metabolic health, even in those ...
GLP-1 weight loss drugs such as Ozempic and Wegovy have taken the world by storm. But some side effects, from the accepted - ...
Changes are coming in 2026 for GLP-1 drugs. Long defined by high prices, shortages and weekly injections, drugs including ...
The study also found that women with a history of GLP-1 use had a 30% higher risk of developing gestational diabetes, a ...
Obesity and diabetes treatment is undergoing a revolution with the advent of GLP-1 drugs, which help manage weight, control ...
Winselow Tucker, president and general manager, Eli Lilly and Company (India) Pvt Ltd, addresses concerns regarding ...
MedPage Today on MSN
GLP-1 Agents Tied to Less Risk of Asthma Exacerbations in Teens With Obesity
Adolescents with overweight or obesity and asthma taking a GLP-1 agent had less risk of asthma exacerbations compared with ...
The Phase II study for diabetes is a 13-week, randomized, double-blind, placebo-controlled and multi-center study to evaluate ...
TipRanks on MSN
Ascletis wins FDA green light for phase II US diabetes trial of oral GLP-1 drug ASC30
Ascletis Pharma, Inc. ( ($HK:1672) ) has provided an update. Ascletis Pharma has received U.S. FDA Investigational New Drug clearance to launch a ...
E! Online on MSN
Oprah Reveals Use of GLP-1 Medications Led to Sobriety
Oprah Winfrey detailed that in addition to weight loss and renewed energy, her use of GLP-1 medications for weight loss also ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results